SAB Biotherapeutics Inc Free Cash Flow Generation Index
SAB Biotherapeutics Inc free cash flow generation index. SAB Biotherapeutics Inc (SABS) has a Free Cash Flow Generation Index of 85.55x as of December 2022. Free cash flow of $18.54 Million represents 86% of operating cash flow ($216.72K).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of SAB Biotherapeutics Inc (2020–2021)
Free cash flow generation index of SAB Biotherapeutics Inc from 2020 to 2021. Historical FCF Generation Index trend for SAB Biotherapeutics Inc across 2 annual periods. See SABS FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
SAB Biotherapeutics Inc Free Cash Flow Generation Index by Year (2020–2021)
SAB Biotherapeutics Inc free cash flow generation index by year from 2020 to 2021. Year-by-year Free Cash Flow Generation Index for SAB Biotherapeutics Inc. For the full cash flow conversion analysis, see SABS cash flow metrics.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2021 | -4.51x | $-8.96 Million | $1.99 Million | $10.94 Million | ▼ -1553.9% |
| 2020 | -0.27x | $-2.73 Million | $10.00 Million | $12.73 Million | — |